{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:37:43Z","timestamp":1770820663583,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jpeds.2015.11.040","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T10:36:41Z","timestamp":1450867001000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Have Changing Palivizumab Administration Policies Led to More Respiratory Morbidity in Infants Born at 32-35 Weeks?"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5188-2512","authenticated-orcid":false,"given":"Arielle","family":"Olicker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis","family":"Tatsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-2516","authenticated-orcid":false,"given":"Kristie","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Trembath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2015.11.040_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jpeds.2012.11.028","article-title":"Why do former preterm infants wheeze?","volume":"162","author":"Martin","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.11.040_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.earlhumdev.2013.07.004","article-title":"Long-term respiratory consequences of premature birth at less than 32 weeks of gestation","volume":"89","author":"Greenough","year":"2013","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jpeds.2015.11.040_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1164\/rccm.201211-2070OC","article-title":"Moderately preterm children have more respiratory problems during their first 5 years of life than children born full term","volume":"187","author":"Vrijlandt","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2015.11.040_bib4","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1017\/S0950268813001738","article-title":"Respiratory morbidity of preterm infants of less than 33 weeks gestation without bronchopulmonary dysplasia: a 12-month follow-up of the CASTOR study cohort","volume":"142","author":"Fauroux","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jpeds.2015.11.040_bib5","first-page":"241","article-title":"Prevention of respiratory syncytial viral infections in late preterm infants","volume":"15","author":"Sankaran","year":"2013","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.jpeds.2015.11.040_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/INF.0000000000000130","article-title":"Increased risk for respiratory syncytial virus-associated community-acquired alveolar pneumonia in infants born at 31-36 weeks of gestation","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2015.11.040_bib7","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1211917","article-title":"Respiratory syncytial virus and recurrent wheeze in healthy preterm infants","volume":"368","author":"Blanken","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2015.11.040_bib8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1542\/peds.112.6.1442","article-title":"Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections","volume":"112","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.11.040_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2007.02.032","article-title":"Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing","volume":"2","author":"Simoes","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.11.040_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1542\/peds.2013-0982","article-title":"Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants","volume":"132","author":"Yoshihara","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.11.040_bib11","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1542\/peds.2009-2345","article-title":"Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections","volume":"124","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.11.040_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1542\/peds.104.3.419","article-title":"Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants","volume":"104","author":"Joffe","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.11.040_bib13","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/archpedi.156.10.1034","article-title":"Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review","volume":"156","author":"Kamal-Bahl","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpeds.2015.11.040_bib14","first-page":"55","article-title":"Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis","volume":"154","author":"Stevens","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpeds.2015.11.040_bib15","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1542\/peds.2004-0959","article-title":"Direct cost analyses of palivizumab treatment in a cohort of at-risk children: evidence from the North Carolina Medicaid program","volume":"114","author":"Wegner","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.11.040_bib16","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/archpedi.160.10.1070","article-title":"Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease","volume":"160","author":"Elhassan","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpeds.2015.11.040_bib17","doi-asserted-by":"crossref","DOI":"10.3310\/hta12360","article-title":"Imunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation","volume":"12","author":"Wang","year":"2008","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jpeds.2015.11.040_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/jp.2014.176","article-title":"Race differences in the association between multivitamin exposure and wheezing in preterm infants","volume":"35","author":"Hibbs","year":"2015","journal-title":"J Perinatol"},{"key":"10.1016\/j.jpeds.2015.11.040_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4236\/ojped.2013.33045","article-title":"Performance of commonly used respiratory questionnaire items in a cohort of infants born preterm","volume":"3","author":"Boggs","year":"2013","journal-title":"Open J Pediatr"},{"key":"10.1016\/j.jpeds.2015.11.040_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ije\/25.3.609","article-title":"Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma","volume":"25","author":"Jenkins","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jpeds.2015.11.040_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations: a review and computer program","volume":"11","author":"Dupont","year":"1990","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jpeds.2015.11.040_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.jpeds.2015.11.040_bib23","unstructured":"PediTools.org. Growth Fenton 2013 [Internet]. 2015 [cited 19 October 2015]. http:\/\/www.peditools.org\/fenton2013\/. Accessed November 25,\u00a02015."},{"key":"10.1016\/j.jpeds.2015.11.040_bib24","doi-asserted-by":"crossref","first-page":"e0125422","DOI":"10.1371\/journal.pone.0125422","article-title":"Long-term burden and respiratory effects of respiratory syncytial virus hospitalization in preterm infants\u2014The SPRING Study","volume":"10","author":"Carbonell-Estrany","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2015.11.040_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12325-015-0204-6","article-title":"Patient reported burden of asthma on resource use and productivity across 11 countries in Europe","volume":"32","author":"Fletcher","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.jpeds.2015.11.040_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1001596","article-title":"Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis","volume":"11","author":"Been","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jpeds.2015.11.040_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/2047-783X-16-5-223","article-title":"Respiratory symptoms in preterm infants: burden of disease in the first year of life","volume":"16","author":"Pramana","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jpeds.2015.11.040_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaci.2012.05.022","article-title":"Long-term outcomes of early-onset wheeze and asthma","volume":"130","author":"Grad","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jpeds.2015.11.040_bib29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamapediatrics.2013.2636","article-title":"Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants, a cohort study","volume":"167","author":"Winterstein","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2015.11.040_bib30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3111\/13696998.2012.690013","article-title":"Cost utility of palivizumab prophylaxis among pre-term infants in the United\u00a0States: a national policy perspective","volume":"15","author":"Mahadevia","year":"2012","journal-title":"J Med Econ"},{"key":"10.1016\/j.jpeds.2015.11.040_bib31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3111\/13696998.2012.672942","article-title":"Cost-effectiveness of palivizumab among pre-term infant populations covered by Medicaid in the United States","volume":"15","author":"Weiner","year":"2012","journal-title":"J Med Econ"},{"key":"10.1016\/j.jpeds.2015.11.040_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.11.040_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/jp.2008.225","article-title":"Economic evaluation of recombinant human copper zinc oxide dismutase administered at birth to premature infants","volume":"29","author":"McBride","year":"2009","journal-title":"J Perinatol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615014523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615014523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T13:22:44Z","timestamp":1537104164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347615014523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":33,"alternative-id":["S0022347615014523"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.11.040","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Have Changing Palivizumab Administration Policies Led to More Respiratory Morbidity in Infants Born at 32-35 Weeks?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.12.029","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.12.073","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}